<DOC>
	<DOCNO>NCT00137306</DOCNO>
	<brief_summary>Comorbid depression consistently link bad outcomes patient substance abuse treatment program . Practice guideline recommend pharmacotherapy comorbid depression symptom persist 4-week `` wash-out '' period detoxification ( e.g. , Veterans Health Administration ; American Psychiatric Association ) . Medications may consider earlier patient current symptom history major depressive disorder ( MDD ) period sobriety . Current efficacy data suggest antidepressant medication improve depression substance use outcomes among comorbid patient Guideline-concordant use antidepressant medication person comorbid substance use depressive disorder , however , routine many VA substance abuse treatment setting .</brief_summary>
	<brief_title>Facilitating Adoption Evidence-Based Depression Management Substance Use Treatment Programs</brief_title>
	<detailed_description>Background : Comorbid depression consistently link bad outcomes patient substance abuse treatment program . Practice guideline recommend pharmacotherapy comorbid depression symptom persist 4-week `` wash-out '' period detoxification ( e.g. , Veterans Health Administration ; American Psychiatric Association ) . Medications may consider earlier patient current symptom history major depressive disorder ( MDD ) period sobriety . Current efficacy data suggest antidepressant medication improve depression substance use outcomes among comorbid patient Guideline-concordant use antidepressant medication person comorbid substance use depressive disorder , however , routine many VA substance abuse treatment setting . Objectives : This study seek develop , implement , test organizational intervention VA substance abuse treatment setting establish guideline-concordant treatment comorbid depression . The intervention assist `` intervention '' program implementation guidelines-based treatment algorithm improve recognition depression initiation pharmacotherapy . Methods : Substance abuse treatment program South Central VISN match program characteristic current depression management practice ( n = 4 ) , `` intervention '' site randomly choose pair . Phase 1 ( complete ) study analyze barrier facilitator translation depression management participate facility , use data inform development translation intervention , implementation tool , depression algorithm . The translation intervention adopt plan base PRECEDE model organizational behavior change include provider education , use local champion , feedback screen data , patient education/activation . The depression management algorithm intervention develop input program staff Advisory Panel depression management translation expert . Phase 2 study implement test intervention . The evaluation examine program- provider-level outcome . Program-level outcome include feasibility , extent adoption algorithm , provider/organizational attitude beliefs intervention 's design effectiveness . Patient-level outcome include depressive symptom , substance use outcome , medication adherence , quality life , service use . Status : Phase 1 study complete . Phase 2 near complete .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Programs : VA 's offering residential intensive outpatient treatment substancerelated disorder VISN 16 Patients : Veterans residential intensive outpatient treatment substancerelated disorder ; positive screen nonsubstanceinduced depressive disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Guideline Adherence</keyword>
	<keyword>Quality Assurance , Health Care</keyword>
</DOC>